Asgar Ali

6.7k total citations
112 papers, 5.3k citations indexed

About

Asgar Ali is a scholar working on Pharmaceutical Science, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Asgar Ali has authored 112 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 83 papers in Pharmaceutical Science, 22 papers in Molecular Biology and 18 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Asgar Ali's work include Advanced Drug Delivery Systems (63 papers), Advancements in Transdermal Drug Delivery (62 papers) and Drug Solubulity and Delivery Systems (21 papers). Asgar Ali is often cited by papers focused on Advanced Drug Delivery Systems (63 papers), Advancements in Transdermal Drug Delivery (62 papers) and Drug Solubulity and Delivery Systems (21 papers). Asgar Ali collaborates with scholars based in India, Saudi Arabia and Pakistan. Asgar Ali's co-authors include Mohd. Aqil, Yasmin Sultana, Abdul Ahad, Syed Sarim Imam, Javed Ali, Sanjula Baboota, Aseem Bhatnagar, Ameeduzzafar Zafar, Gaurav Mittal and Himanshu Gupta and has published in prestigious journals such as Carbohydrate Polymers, International Journal of Pharmaceutics and Journal of Pharmaceutical Sciences.

In The Last Decade

Asgar Ali

110 papers receiving 5.1k citations

Peers

Countries citing papers authored by Asgar Ali

Since Specialization

Citations

This map shows the geographic impact of Asgar Ali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Asgar Ali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Asgar Ali more than expected).

Fields of papers citing papers by Asgar Ali

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Asgar Ali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Asgar Ali. The network helps show where Asgar Ali may publish in the future.

Co-authorship network of co-authors of Asgar Ali

This figure shows the co-authorship network connecting the top 25 collaborators of Asgar Ali. A scholar is included among the top collaborators of Asgar Ali based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Asgar Ali. Asgar Ali is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Receptor-mediated nose-to-brain delivery of drug combination-loaded polymeric nanocarriers for the treatment of glioblastoma- current progress and future perspectives part I: receptor-mediated nose-to-brain delivery approaches for glioblastoma 2025 ·Expert Opinion on Drug Delivery ·Zufika Qamar, (unknown), (unknown), Mariya Khan, (unknown), Shweta Dang, Sanjula Baboota, Asgar Ali, Javed Ali	0
2	Tailoring and Evaluation of Berberine Loaded Transethosomal Gel for Effective Transdermal Delivery: Optimization, Characterization, and in vitro Evaluation 2024 ·Journal of Cluster Science ·(unknown), Asad Ali, (unknown), (unknown), (unknown), Mohd. Aqil, Asgar Ali	1
3	An overview of phospholipid enriched-edge activator-based vesicle nanocarriers: new paradigms to treat skin cancer 2024 ·Journal of drug targeting ·(unknown), Asad Ali, (unknown), (unknown), (unknown), Mohd. Aqil, Mohd Mujeeb, Asgar Ali	8
4	Development of Forskolin and rutin-loaded polymeric nanoparticles for enhancement of topical ocular delivery: Optimization, in-vitro, ex-vivo, and toxicity evaluation 2023 ·Journal of Drug Delivery Science and Technology ·(unknown), Ameeduzzafar Zafar, Farhan Jalees Ahmad, Mohammad Khalid, Asgar Ali	13
5	Binary Ethosomal Gel for Enhanced Transdermal Delivery of Tazarotene: Development, Refinement, in vitro Evaluation, and Skin Penetration Investigations 2023 ·Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ) ·(unknown), Yasir Qasim Almajidi, Asgar Ali	1
6	Combination drug loaded lipid-based nanocarriers as treatment entity for battling glioblastoma multiforme 2023 ·Journal of Drug Delivery Science and Technology ·Zufika Qamar, Ali Sartaj, Mohammad Kashif Iqubal, (unknown), (unknown), Javed Ali, Asgar Ali, Sanjula Baboota	8
7	Intranasal inorganic cerium oxide nanoparticles ameliorate oxidative stress induced motor manifestations in haloperidol-induced parkinsonism 2023 ·Inflammopharmacology ·Mohammad, (unknown), (unknown), (unknown), Musarrat Husain Warsi, Mohammed A. S. Abourehab, Gaurav Jain, Prashant Kesharwani, Asgar Ali	4
8	Formulation of Lipid-Based Nanocarriers of Lacidipine for Improvement of Oral Delivery: Box-Behnken Design Optimization, In Vitro , Ex Vivo , and Preclinical Assessment 2022 ·Assay and Drug Development Technologies ·(unknown), Ameeduzzafar Zafar, Javed Ali, (unknown), Saba Khan, Syed Sarim Imam, Mohd Yasir, Asgar Ali	9
9	Formulation by design based risperidone nano soft lipid vesicle as a new strategy for enhanced transdermal drug delivery: In-vitro characterization, and in-vivo appraisal 2017 ·Materials Science and Engineering C ·Syed Sarim Imam, Abdul Ahad, Mohd. Aqil, Mohd Akhtar, Yasmin Sultana, Asgar Ali	72
10	Ameliorative efficacy of bioencapsulated Chironomous larvae with Shilajit on Zebrafish (Danio rerio) exposed to Ionizing radiation 2017 ·Applied Radiation and Isotopes ·Mohamed Saiyad Musthafa, (unknown), Sadasivam Anbumani, Asgar Ali, (unknown), Bilal Ahmad Paray, Mohammad K. Al‐Sadoon, M. Shanmugavel, (unknown), Ramasamy Harikrishnan	4
11	In vitroand preclinical assessment of factorial design based nanoethosomes transgel formulation of an opioid analgesic 2015 ·Artificial Cells Nanomedicine and Biotechnology ·Shakeeb Ahmed, Syed Sarim Imam, (unknown), Asgar Ali, Mohd. Aqil, (unknown)	35
12	Nanostructured lipid (NLCs) carriers as a bioavailability enhancement tool for oral administration 2014 ·Drug Delivery ·Bharti Gaba, Mohammad Fazil, Asgar Ali, Sanjula Baboota, Jasjeet Kaur Sahni, Javed Ali	112
13	Part I: Development and optimization of solid‐lipid nanoparticles using Box–Behnken statistical design for ocular delivery of gatifloxacin 2012 ·Journal of Biomedical Materials Research Part A ·Mohd Abul Kalam, Yasmin Sultana, Asgar Ali, Mohd. Aqil, Anil K. Mishra, Ibrahim A. Aljuffali, Aws Alshamsan	49
14	Formulation and optimization of nanotransfersomes using experimental design technique for accentuated transdermal delivery of valsartan 2011 ·Nanomedicine Nanotechnology Biology and Medicine ·Abdul Ahad, Mohd. Aqil, Kanchan Kohli, Yasmin Sultana, (unknown), Asgar Ali	170
15	Biodegradable levofloxacin nanoparticles for sustained ocular drug delivery 2010 ·Journal of drug targeting ·Himanshu Gupta, Mohd. Aqil, R. K. Khar, Asgar Ali, Aseem Bhatnagar, Gaurav Mittal	111
16	Design, development, physicochemical, in vitro and in vivo evaluation of monolithic matrix type transdermal patches containing nitrendipine 2009 ·Pharmaceutical Development and Technology ·Ashu Mittal, (unknown), Asgar Ali, (unknown)	16
17	Basil Oil is a Promising Skin Penetration Enhancer for Transdermal Delivery of Labetolol Hydrochloride 2008 ·Drug Development and Industrial Pharmacy ·Rahul Jain, Mohd. Aqil, Abdul Ahad, Asgar Ali, Roop K. Khar	46
18	Review of Ocular Drug Delivery 2006 ·Current Drug Delivery ·Yasmin Sultana, Surendra Jain, Mohd. Aqil, Asgar Ali	101
19	A Three-Way Comparative Study on the Efficacy of Twin Sol to Gel Systems and Marketed Eye Drops of Pefloxacin Mesylate 2004 ·Journal of Ocular Pharmacology and Therapeutics ·Yasmin Sultana, (unknown), Asgar Ali, Mohd. Aqil	7
20	Recent Approaches in Insulin Delivery 1998 ·Drug Development and Industrial Pharmacy ·(unknown), Asgar Ali	33

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact